- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Multiple Myeloma in Germany
Total 1132 results
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedClear Cell Renal Cell Carcinoma | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Recurrent Adult Lymphoblastic Lymphoma | Untreated Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia in Remission | Childhood Acute... and other conditionsUnited States, Germany, Italy
-
Janssen Research & Development, LLCCompletedHigh-risk Smoldering Multiple MyelomaUnited States, United Kingdom, Belgium, Germany, France, Spain, Korea, Republic of, Australia, Israel, Greece, Sweden
-
Prof. Dr. Richard F SchlenkTerminatedAML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)Germany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Recurrent Adult Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Non-Hodgkin Lymphoma | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Plasma Cell MyelomaUnited States, Germany, Italy
-
AvenCell Europe GmbHAllucent (NL) BVRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryGermany, Netherlands
-
Cornerstone PharmaceuticalsTerminatedRelapsed/Refractory Acute Myeloid LeukemiaUnited States, Spain, Korea, Republic of, France, Australia, Belgium, Austria, Germany, Poland
-
Aptose Biosciences Inc.RecruitingRelapsed or Refractory Acute Myeloid LeukemiaUnited States, Germany, Spain, Korea, Republic of, Australia, New Zealand
-
Novartis PharmaceuticalsActive, not recruitingMultiple Myeloma (MM)United States, Italy, Israel, Germany, Japan, Spain, Australia, Norway
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedHematopoietic and Lymphoid Cell Neoplasm | Diffuse Large B-Cell Lymphoma | Refractory Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Plasma Cell Myeloma | Refractory Chronic Lymphocytic Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Chronic Phase Chronic Myelogenous... and other conditionsUnited States, Germany, Italy
-
SanofiCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Diffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Prolymphocytic Leukemia | Refractory... and other conditionsUnited States, Germany, Denmark
-
Wuerzburg University HospitalClinAssess GmbH; Arbeitsgemeinschaft medikamentoese TumortherapieActive, not recruitingNewly Diagnosed Multiple MyelomaGermany, Austria
-
Molecular Partners AGCompletedMultiple Myeloma in RelapsePoland, Italy, Germany, Denmark, Czechia, Austria
-
Wuerzburg University HospitalCelgene Corporation; ClinAssess GmbHActive, not recruitingPreviously Untreated Symptomatic Multiple MyelomaGermany
-
Arog Pharmaceuticals, Inc.RecruitingRelapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States, Germany, Spain, Italy, France, Canada
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgen; Assign Data Management and Biostatistics GmbHActive, not recruitingMultiple MyelomaAustria, Germany, Israel
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Polyphor Ltd.Completed
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
Novartis PharmaceuticalsCompletedSmoldering Multiple MyelomaGermany, United States, France
-
Hoffmann-La RocheCompletedMultiple Myeloma, NeoplasmsUnited States, China, France, Spain, United Kingdom, Germany
-
Patrys Ltd.Completed
-
iOMEDICO AGCompleted
-
University of LeipzigMundipharma Pte Ltd.; Celgene Corporation; AmgenUnknown
-
University Hospital, BonnUnknown
-
European Myeloma NetworkCompletedMultiple Myeloma | Hematologic MalignanciesSpain, Sweden, Germany, Italy
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Heidelberg UniversityMerck Sharp & Dohme LLCUnknown
-
Universitätsklinikum Hamburg-EppendorfClinical Trial Center North (CTC North GmbH & Co. KG); RiemserActive, not recruiting
-
AbbVieCompletedMultiple Myeloma (MM)United States, Argentina, Australia, Brazil, Canada, Croatia, Czechia, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Norway, Poland, Romania, Saudi Arabia, Slovenia, Spain, Taiwan, Turkey
-
Prof. Dr. Andreas EngertThe Clinical Trials Centre CologneTerminated
-
Gesellschaft fur Medizinische Innovation - Hamatologie...Completed
-
Novartis PharmaceuticalsCompletedMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaItaly, Australia, Germany, Spain, France, Japan, United States
-
European Organisation for Research and Treatment...UnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmFrance, Belgium, Netherlands, Germany, Italy
-
iOMEDICO AGStemline Switzerland GmbH; Climedo Health GmbHRecruitingMultiple MyelomaAustria, Germany
-
iOMEDICO AGCompleted
-
Stichting European Myeloma NetworkFondazione EMN Italy OnlusCompletedMultiple MyelomaGermany, Italy
-
University of RegensburgClinAssess GmbHUnknownMultiple MyelomaGermany
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Cytopenia | Refractory Anemia With Excess BlastsUnited States, Australia, Spain, Italy, Germany, France, Sweden, Denmark
-
PfizerCompletedAdvanced Multiple MyelomaGermany, United States, Spain, United Kingdom, Belgium, Canada, France, Greece
-
University of CologneCompletedMultiple Myeloma | Hodgkin's Disease | Non-Hodgkin-LymphomaGermany
-
Boehringer IngelheimCompletedMultiple MyelomaGermany, France
-
University of LeipzigCompleted
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
Celgene CorporationCompletedNewly Diagnosed Multiple MyelomaSpain, Netherlands, Austria, Australia, Italy, Russian Federation, United Kingdom, Israel, Belgium, Greece, Germany, Poland, Turkey, France, Denmark, Czech Republic, Belarus, Georgia, Ireland, Sweden, Switzerland, Ukraine
-
Wuerzburg University HospitalEuropean UnionActive, not recruitingMultiple MyelomaFrance, Germany, Spain
-
iOMEDICO AGActive, not recruitingMultiple Myeloma | Patient Satisfaction | Personal Satisfaction | Newly Diagnosed | Transplant Ineligible | Patient PreferenceGermany
-
Merck KGaA, Darmstadt, GermanyTerminatedMultiple Myeloma | Non-Small Cell Lung CancerGermany
-
Genzyme, a Sanofi CompanyAnorMEDCompletedLymphoma, Non-Hodgkin | Multiple MyelomaGermany